CMS Measure ID: #290
Collection Type: CQM, MVP
Reporting Frequency: Once per patient per year
Outcome: No
High Priority: No
NQS Domain: Effective Clinical Care
Measure Age: > 2 years
Instructions
This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of Parkinson’s Disease seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
NOTE: Patient encounters for this measure conducted via telehealth (e.g., encounters coded with GQ, GT, 95, or POS 02 modifiers) are allowable
Measure Submission Type:
The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted for registry submissions; however, these codes may be submitted for those registries that utilize claims data.
Description
Percentage of all patients with a diagnosis of Parkinson’s Disease [PD] who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period.
2022 Benchmarks (from 2020 CMS data)
Registry
Topped out: Yes
Capped at 7: Yes
Minimum: 0 – 64.06
Decile 3: 64.07 – 86.35
Decile 4: 86.36 – 94.43
Decile 5: 94.44 – 99.99
Decile 10: 100 – 100
Denominator
All patients with a diagnosis of Parkinson’s Disease
DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.
Denominator Criteria (Eligible Cases):
All patients regardless of age
AND
Diagnosis for Parkinson’s disease (ICD-10-CM): G20
AND
Patient encounter during the performance period (CPT): 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99242*, 99243*, 99244*, 99245*, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99421, 99422, 99423, 99441, 99442, 99443, 99483
Numerator
Patients who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period
Definitions:
Assessed – use of a screening tool or discussion with the patient or care partner. Please see “Opportunity for Improvement” section below forsuggestions on possible screening tools.
Psychosis – includes hallucinations, illusions, delusions, paranoia.
Numerator Instructions:
Opportunity for Improvement
The following screening tools may be helpful for use in practice:
For depression:
Geriatric Depression scale Beck Depression
Hamilton Depression scale
Patient Health Questionnaire 2 (PHQ2)
Patient Health Questionnaire 9 (PHQ9)
Montgomery-Asberg Depression Rating Scale (MADRS)
For Anxiety:
Beck Anxiety Inventory
Hospital Anxiety and Depression Scale
Self-rating Anxiety Scale
Anxiety Status Inventory
Strait Trait Anxiety Inventory
Hamilton Anxiety Rating Scale
Parkinson Anxiety Scale
(PAS)
For Psychosis:
Parkinson psychosis rating scale
Rush hallucination inventory
Baylor hallucination questionnaire
Neuropsychiatric inventory (NPI or NPI-Q)
Brief psychiatric rating scale
Positive and negative syndrome scale
Schedule for assessment of positive symptoms
Unified Parkinson disease rating scale Part I
Numerator Options:
Performance Met:
Depression, anxiety, apathy, AND psychosis assessed (G2121)
OR
Performance Not Met:
Depression, anxiety, apathy, AND psychosis not assessed (G2122)